Latest Capital Raising And Placements News

4DMedical Limited reported a 56% jump in FY2025 operating revenue driven by SaaS growth, while narrowing its net loss to $30.1 million. The company also secured $13.9 million in capital and a $10 million funding facility to accelerate product commercialisation.

Sparc Technologies reported a narrower FY25 loss alongside progress in green hydrogen and graphene additive projects, supported by government grants and a successful capital raise.

WCM Global Growth Limited reported a robust 53% rise in net profit for FY2025, driven by strong portfolio returns and a successful capital raise, prompting an increased final dividend and upward revision of future dividends.

Amplia Therapeutics has successfully raised A$2.65 million through its Share Purchase Plan, exceeding expectations and bolstering funding for pivotal clinical trials of its lead drug narmafotinib.

Story-i Limited has agreed to acquire LIT Energy Network Australia for AUD 8 million, targeting Vietnam’s booming electric motorcycle market. The deal comes as Story-i prepares for ASX delisting and a $5 million capital raise.

Golden Mile Resources has raised $510,823 through a discounted private placement to fund further exploration at its Pearl Copper Project in Arizona and pursue strategic acquisitions.

Orion Minerals has successfully closed a Share Purchase Plan raising nearly A$2 million, reinforcing its financial footing as it accelerates towards production. The strong backing from South African shareholders highlights growing investor confidence.

Bastion Minerals has resumed ASX trading under a refreshed leadership team, announcing a JORC-compliant resource at its ICE Copper-Gold Project and completing multiple capital raises to support its renewed exploration focus.

Norfolk Metals advances its Carmen Copper Project in Chile with a newly granted drill permit and a firm $3.5 million capital raise, positioning the company for a maiden drilling campaign targeting significant copper mineralisation.

Pinnacle Minerals has progressed metallurgical reviews and exploration across its rare earth, lithium, and heavy mineral sands projects, supported by a recent $1.76 million capital raising to fund ongoing and new opportunities.

Bio-Gene Technology Limited has secured $2.45 million to fund critical safety studies and scale-up production of its novel insecticides Flavocide and Qcide, positioning the company for upcoming regulatory approvals and commercial partnerships.

Tambourah Metals reports significant gold assay results extending mineralisation at Tambourah King and confirms high-grade antimony, silver, and copper at Speewah North, alongside corporate updates including a new CEO appointment and capital raising.